Not Yet RecruitingNot Applicable

Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

200 participantsStarted 2026-07-01

Plain-language summary

Our study will assess the prevalence of obesity among patients with (MASLD) and to evaluate the characteristics of lean MAFLD patients.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients aged \>18 years old * diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques Exclusion Criteria: * Patients aged ≤18 years old. * Pregnancy. * Presence of malignancy * Type I DM. * Fatty liver patients on treatment by statin derivatives or other medications. * Fatty liver patients undergone bariatric surgerie

What they're measuring

Prevalence of Obesity and Clinical Characteristics of Lean MASLD Patients

Timeframe: 24 month

Trial details

NCT IDNCT07451366

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-01

Contact for this trial

Amira M. Abdelmawgod, MD, Assuit University

+201012760437 amiramohmad60@gmail.com

View on ClinicalTrials.gov More Lean MASLD trials